223 related articles for article (PubMed ID: 36577899)
21. Oncological Outcomes of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated With Preoperative Chemoradiotherapy.
Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Dis Colon Rectum; 2017 May; 60(5):469-476. PubMed ID: 28383446
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant therapy does not affect lymph node ratio in rectal cancer.
Chang KH; Kelly NP; Duff GP; Condon ET; Waldron D; Coffey JC
Surgeon; 2016 Oct; 14(5):270-3. PubMed ID: 26148760
[TBL] [Abstract][Full Text] [Related]
23. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
24. Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma.
Hagemans JAW; Rothbarth J; van Bogerijen GHW; van Meerten E; Nuyttens JJME; Verhoef C; Burger JWA
Ann Surg Oncol; 2019 Apr; 26(4):1134-1141. PubMed ID: 30725310
[TBL] [Abstract][Full Text] [Related]
25. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
[TBL] [Abstract][Full Text] [Related]
26. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of the distribution of lymph node metastasis in rectal cancer after neoadjuvant chemoradiation.
Lee SY; Kim CH; Kim YJ; Kim HR
J Surg Oncol; 2018 Mar; 117(3):514-522. PubMed ID: 29094377
[TBL] [Abstract][Full Text] [Related]
28. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
[TBL] [Abstract][Full Text] [Related]
29. Lateral pelvic lymph node metastasis in T2 low rectal cancer: is TME alone sufficient for cure?
Ouchi A; Inoue M; Sato Y; Takamizawa Y; Kinoshita T; Moritani K; Komori K; Tsukamoto S; Shimizu Y; Kanemitsu Y
Jpn J Clin Oncol; 2023 Apr; 53(5):386-392. PubMed ID: 36722355
[TBL] [Abstract][Full Text] [Related]
30. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer.
De Nardi P; Guarneri G; Canevari C; Tamburini A; Slim N; Passoni P; Rosati R
Colorectal Dis; 2019 Sep; 21(9):1017-1024. PubMed ID: 31077550
[TBL] [Abstract][Full Text] [Related]
33. Rectal cancer with synchronous inguinal lymph node metastasis without distant metastasis. A call for further oncological evaluation.
Abd El Aziz MA; McKenna NP; Jakub JW; Hallemeier CL; Kelley SR; Jin Z; Mathis KL
Eur J Surg Oncol; 2022 May; 48(5):1100-1103. PubMed ID: 34953643
[TBL] [Abstract][Full Text] [Related]
34. What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer.
Lee WS; Lee SH; Baek JH; Lee WK; Lee JN; Kim NR; Park YH
Radiat Oncol; 2013 Aug; 8():202. PubMed ID: 23957923
[TBL] [Abstract][Full Text] [Related]
35. Short- and long-term outcomes of surgical treatment for inguinal lymph node metastasis in rectal and anal canal adenocarcinoma.
Ito S; Tsukamoto S; Kagawa H; Kanemitsu Y; Hiro J; Kawai K; Nozawa H; Takii Y; Yamaguchi T; Akagi Y; Suto T; Hirano Y; Ozawa H; Komori K; Ohue M; Toiyama Y; Shinji S; Minami K; Shimizu T; Sakamoto K; Uehara K; Sugihara K; Kinugasa Y; Ajioka Y
Colorectal Dis; 2024 Jun; ():. PubMed ID: 38881213
[TBL] [Abstract][Full Text] [Related]
36. Rectal cancer and inguinal metastases: prognostic role and therapeutic indications.
Tocchi A; Lepre L; Costa G; Liotta G; Mazzoni G; Agostini N; Miccini M
Dis Colon Rectum; 1999 Nov; 42(11):1464-6. PubMed ID: 10566535
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the histopathologic status of rectal adenocarcinoma and its regional lymph nodes after neoadjuvant therapy, and its relation to the duration of disease-free survival.
Karimi F; Tabriz HM; Amoli HA; Nazar E; Vaezi AA
Indian J Pathol Microbiol; 2022; 65(1):49-54. PubMed ID: 35074965
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery.
Hajibandeh S; Hajibandeh S; Matthews J; Palmer L; Maw A
Surgery; 2020 Sep; 168(3):486-496. PubMed ID: 32620303
[TBL] [Abstract][Full Text] [Related]
39. Metabolic and magnetic resonance imaging: complementary modalities for the preoperative assessment of lateral pelvic lymph nodes in rectal cancer.
Cribb BI; Kong JC; Kay JS; Tan TH; Noe GD; Gest B; Lee AB; Oon SF; Warrier SK; Heriot AG
ANZ J Surg; 2023 Jan; 93(1-2):196-205. PubMed ID: 36074654
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
